1. Yissum’s Mission
To promote the transfer of Hebrew University technology
for the benefit of society, while maximizing returns to
support research, education and scientific excellence
Yissum = Hebrew for ‘application’

2. The Technology Transfer Process
Yissum protects the IP
and commercializes it
HUJI
researchers
The Industry
discover new
partner pays
Research Money invention &
Yissum for
submit
the license to
disclosure
use its IP
Yissum pays royalties to
the researchers and HUJI

3. A Heritage of Excellence
43% of Israel’s
biotechnology 30% of all Israeli
>1/3 of PhD research academic scientific
students in Israel research
23,000 students
1,000 researchers
(staff members)
1,600 Post-Graduate
students in
biotechnology
5 affiliated hospitals
6 Campuses
3,500 Research >100 Research
projects
centers
Over 400 Researchers
in applied sciences

4. Areas of Expertise
Pharmacology and
Agriculture
Medicine
Brain Research Engineering and
Computer Science
Nanoscience and
Cleantech
Advanced Materials
Education Veterinary

5. 48 Years of Transferring Technologies
7,736 patents
2,212 inventions
566 licenses
74 spin-offs
Products based on Hebrew University technologies &
commercialized by Yissum generate over $2 billion in annual sales

6. Israel Tech Transfer Organization
Yissum
40%
Yeda
21%
Yissum’s innovations
Yissum - reflect 40% of the total
a leading number of projects
member of the available for licensing
ITTN *
by Israeli technology
Technion transfer companies.
13%
Bar Ilan
5%
Ben
Ramot TLV Gurion
8% Carmel
Medical Mor Hadasit 1% 4%
Center 2% 5%
1%
* By number of available technologies

7. Intellectual Property
Materials & 2011 Snapshot
Chemistry Agriculture, 150 new inventions
20% Food &
Nutrition,
154 new patent
Cleantech applications
14% 54 new patents granted
Micro & Opto
Electronics
A variety of 5% Intellectual Property at HU
new Computer
Yissum owns all IP
inventions Science & developed at HU
Engeneering Researchers receive
11%
40-60% of revenues
Life Science &
Biotechnology
50%

8. Projects Available for Licensing 2012
Materials & Agriculture,
Nanotechnology Food &
15% Nutrition,
Cleantech
13%
Applied physics
4%
Over 400
Computer
technologies Science &
Engeneering
Life Science & 13%
Biotechnology
53% Education
1%
Homeland
Security
1%

9. Yissum’s Biotech Product Pipeline:
Phase I Phase II Phase III
Vekacia ® (Novagali)
Cyclokat ® (Novagali)
Ladostigil, (Avraham)
BC819 (Biocancell)
Anti Angiogenic (Tiltan)
MRX4 (Morria)
MRX6 (Morria)
Acc. Levodopa (Intec)
Acc. Zalepon (Intec)
LABR-312 ( Biorest)
CatioProst ® (Novagali)
BL7040 (Bioline Rx)
AB103 (Atox Bio)
PRX105 (Protalix)
Apocell (Enlivex)
CCS/C (Nasvax)
EPOdure (Medgenics)
Protexia (Pharmathene)
Acc. Baclofen (Intec)
Cortiject ® (Novagali)
MM-002 (Moebius)

10. 74 Spin-Off Companies Created Since 1964

11. Global Reach

12. Success Stories - Exelon
Exelon®
For Treatment of Symptoms Alzheimer’s Disease and
Dementia
Prof. Marta Weinstock-Rosin
Department of Pharmacology, Faculty of Medicine
The Hebrew University of Jerusalem
2010 sales over $1 Billion

13. Success Stories - Doxil
DOXIL® - Doxorubicin HCI liposome injection
Alza’s Lead Product for Oncology
Prof. Yechezkel Barenholz
Department of Biochemistry, Faculty of Medicine
The Hebrew University of Jerusalem
Prof. Alberto Gabizon
Hadassah University Hospital Jerusalem
2010 sales over $500 million

14. Success Stories - Tomatoes
Long Shelf Life Tomatoes
The world’s most popular cocktail hybrids for year
round greenhouse production
Prof. Nachum Kedar
Prof. Haim Rabinowich
Department of Field Crops, Vegetables and Genetics:
Faculty of Agriculture, Food and Environmental
Sciences
The Hebrew University Rehovot Campus

15. Success Stories - Peppers
Hybrid Peppers
Breeding of Blocky type pepper hybrids for growing under
mild winter conditions. Market leader in Spain, Israel &
Mexico In collaboration with Zeraim Gedera (Fully owned
by Syngenta)
Dr. Yonatan Elkind
Department of Field Crops, Vegetables and Genetics:
Faculty of Agriculture, Food and Environmental Sciences
The Hebrew University Rehovot Campus

16. Success Stories - Mobileye
Mobileye
Advanced vision based driver assistance system for
accident prevention
Prof. Amnon Shashua
Computer Science & Engineering, Faculty of Science
The Hebrew University of Jerusalem
2010 Valuation of $740 million
(Investment by Goldman Sachs & others)

17. Products on the Market
The innovative cationic Periochip - slow drug
emulsion for the treatment release for periodentitis
of dry eye symptoms
Prof. Michael Friedman &
Prof. Simon Benita Prof. Doron Steinberg
Bioresorbable
Supra-Vir - Acyclovir cream for Adhesion Barrier
HSV topical treatment reduces the severity
Moisturizing
of post-operative
Prof. Elka Touitou Eye Drops
cardiac adhesions
Prof. Shabtay
Dikstein Prof. Daniel Cohn